Research Studies
Researchers: C₂N partners with many academic and research institutions interested in using C₂N neurodegenerative biomarkers in pre-clinical and clinical research studies (e.g., Alzheimer’s disease). If you wish to discuss C₂N biomarkers or the use of the Precivity™ tests in your research studies, please complete the following form. A C₂N representative will be in contact once your information has been received.
For immediate questions, please reach out at research@c2n.com or call 1.877.226.3424.
* = Mandatory fields